Applications are open
Apply Today
Relative to white patients, racial and ethnic groups saw a sharper decline in access to medicines to treat opioid use disorder during the early stages of the COVID-19 pandemic—intensifying pre-pandemic disparities, says a University of Michigan researcher.
Policy shift could improve access to buprenorphine for opioid use disorder, but stigma and training still pose significant challenge.
A new review of opioid misuse prevention policies across the United States analyzed the effectiveness of each policy on addressing prescribing, patient behavior, and patient health related outcomes.
As the nation continues to battle an epidemic of addiction and overdose related to opioids and other drugs, several teams of University of Michigan researchers have received millions of dollars in new federal funding to address the issue head-on.
Broad distribution of the opioid reversal drug naloxone is highly cost-effective in reducing fatal overdoses, according to a new University of Michigan study.
As the U.S. opioid crisis gained steam a decade ago, Michigan was flooded by pain pills by suppliers and distributors who seemed more focused on sales than the drugs’ dangers, according to recently released documents.